BMS 100 mg 3623 (Reyataz 100 mg)
Generic Name: atazanavir
Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 100 mg 3623
Reyataz
- Generic Name
- atazanavir
- Imprint
- BMS 100 mg 3623
- Strength
- 100 mg
- Color
- Blue & White
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-3623
- Inactive Ingredients
-
crospovidone,
lactose monohydrate,
magnesium stearate,
gelatin,
FD&C Blue No. 2,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
isopropyl alcohol,
ammonia,
propylene glycol,
butyl alcohol,
alcohol,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
More about Reyataz (atazanavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.